Experts in on-line monitoring
Senzime’s proprietary products developed for health care brings
quality to life by early detection of complications in patients
Senzime develops patient-oriented systems enabling automated and continuous monitoring of vital substances such as glucose and lactate in blood and tissue. Based on Senzime’s patented biosensor technology, the company offers complete patient monitoring systems for the health care market. Senzime’s products consist of the CliniSenz Analyzer and OnZurf Probe that make it possible, among other things, to detect post-operative complications significantly earlier than by conventional methods, thus contributing to improved patient care and lower health care costs. The company’s share is listed on Aktietorget, Stockholm.